olopatadine hydrochloride (Sandoz Inc.)
Welcome to the PulseAid listing for the olopatadine hydrochloride drug offered from Sandoz Inc.. This Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sandoz Inc. |
NON-PROPRIETARY NAME: | olopatadine hydrochloride |
SUBSTANCE NAME: | OLOPATADINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] |
ROUTE: | OPHTHALMIC |
DOSAGE FORM: | SOLUTION/ DROPS |
MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
START MARKETING DATE: | 2015-09-15 |
END MARKETING DATE: | 0000-00-00 |
olopatadine hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | olopatadine hydrochloride from Sandoz Inc. |
LABELER NAME: | Sandoz Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(mg/mL) |
START MARKETING DATE: | 2015-09-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 61314-271_4acb46b1-dc71-4920-a275-69344ad50164 |
PRODUCT NDC: | 61314-271 |
APPLICATION NUMBER: | NDA020688 |
Other OLOPATADINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: